Indications and operative procedures for neuroendocrine liver metastases;Indikatorisches und Operatives Spektrum bei Neuroendokrinen Lebermetastasen

Chirurg

Volumn 80, Issue 2, 2009, Pages 113-121

  Musholt, T J ^a   Lang, H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Indications for liver resection; Liver transplantation; Neuroendocrine tumors; Resectability

Indexed keywords

ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; INTESTINE TUMOR; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; METASTASIS; MORTALITY; NEUROENDOCRINE TUMOR; PATHOLOGY; PROGNOSIS; SMALL INTESTINE; SURVIVAL RATE;

FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60649121983     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-008-1614-7     Document Type: Article

References (60)

1. Ahlman H, Nilsson O, Mcnicol AM et al (2008) Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology 87:40-46
2. Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 19:903-908
3. Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490-500
4. Bonney GK, Gomez D, Rahman SH et al (2008) Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience. JOP 9:19-25
5. Cahlin C, Friman S, Ahlman H et al (2003) Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc 35:809-810
6. Carty SE, Jensen RT, Norton JA (1992) Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112:1024-1031
7. Chamberlain RS, Canes D, Brown KT et al (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190:432-445
8. Chambers AJ, Pasieka JI, Dixon E et al (2008) The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery 144:645-651
9. Chen H, Hardacre JM, Uzar A et al (1998) Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187:88-92
10. Coppa J, Pulvirenti A, Schiavo M et al (2001) Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc 33:1537-1539
11. Danforth DN Jr, Gorden P, Brennan MF (1984) Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 96:1027-1037
12. Dousset B, Saint-Marc O, Pitre J et al (1996) Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 20:908-914
13. Elias D.Ouellet JF, De Baere T et al (2002) Preoperative selective portal vein embolization before hepatectomyfor liver metastases: long-term results and impact on survival. Surgery 131:294-299
14. Eriksson J, Stalberg R Nilsson A et al (2008) Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors. World J Surg 32:930-938
15. Fernandez JA, Robles R, Marin C et al (2003) Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc 35:1832-1833
16. Florman S.Toure B, Kim L et al (2004) Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 8:208-212
17. Forrer F, Waldherr C, Maecke H R et al (2006) Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumors. Anticancer Res 26:703-707
18. Givi B, Pommier SJ,Thompson AK et al (2006) Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery 140:891-898
19. Gomez D, Malik HZ, Al-Mukthar A et al (2007) Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors. HPB 9:345-351
20. Grover AC, Libutti SK, Pingpank JF et al (2004) Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. Surgery 136:1176-1182
21. Gurusamy KS, Imber C, Davidson BR (2008) Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg 684150
22. Hemming AW, Reed Al, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686-691
23. Hwang S, Lee YJ, Lee SG et al (2008) Surgical treatment of primary neuroendocrine tumors of the liver. J Gastrointest Surg 12:725-730
24. Jaeck D, Oussoultzoglou E, Bachellier P et al (2001) Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery. World J Surg 25:689-692
25. Knigge U, Hansen CR Stadii F (2008) Interventional treatment of neuroendocrine liver metastases. Surgeon 6:232-239
26. Kuvshinoff B, Fong Y (2007) Surgical therapy of liver metastases. Semin Oncol 34:177-185
27. Lang H (2007) Liver resection: Part I. Anatomy and operative planning. Chirurg 78:761-774
28. Lang H, Oldhafer KJ, Weimann A et al (1997) Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 225:347-354
29. Lang H, Schlitt HJ, Schmidt H et al (1999)Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients. Langenbeck's Arch Surg 384:370-377
30. Le Treut YP, Delpero Jr, Dousset B et al (1997) Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 225:355-364
31. Le Treut YP, Gregoire E, Belghiti J et al (2008) Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant 8:1205-1213
32. LehnertT (1998) Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 66:1307-1312
33. Madeira I, Terris B, Voss M et al (1998) Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43:422-427
34. Makridis C, Oberg K, Juhlin C et al (1990) Surgical treatment of mid-gut carcinoid tumors. World J Surg 14:377-383
35. Martin JK Jr, Moertel CG, Adson MA et al (1983) Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 118:537-542
36. Mazzaferro V, Pulvirenti A, Coppa J (2007) Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol 47:460-466
37. Mcentee GR Nagorney DM, Kvols LK et al (1990) Cytoreductivé hepatic surgery for neuroendocrine tumors. Surgery 108:1091-1096
38. Modlin IM, Champaneria MC, Chan AK et al (2007) A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 102:1464-1473
39. Modlin IM, Kidd M, Drozdov I et al (2008) Pharmacotherapy of neuroendocrine cancers. Expert Opin Pharmacother 9:2617-2626
40. Nagino M, Kamiya J, Nishio H et al (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243:364-372
41. Nave H, Mossinger E, Feist H et al (2001 ) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129:170-175
42. Nilsson O, Cutsem E Van, Delle Fave G et al (2006) Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 84:212-215
43. Norton JA (2005) Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. Best Pract Res Clin Gastroenterol 19:577-583
44. Norton JA, Warren RS, Kelly MG et al (2003) Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 134:1057-1063
45. Olausson M, Friman S, Cahlin C et al (2002) Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg 26:998-1004
46. Panzuto F, Nasoni S, Falconi M et al (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12:1083-1092
47. Pape UF, Jann H, Muller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256-265
48. Que FG, Sarmiento JM, Nagorney DM (2006) Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Adv Exp Med Biol 574:43-56
49. Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386-1394
50. Rindi G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395-401
51. Rindi G, Kloppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757-762
52. Rosenau J, Bahr MJ, Wasielewski R Von et al (2002) KÍ67, E-cadherin and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 73:386-394
53. Sarmiento JM, Heywood G, Rubin J et al (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197:29-37
54. Soreide O, Berstad T, Bakka A et al (1992) Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111:48-54
55. SteinmullerT, Kianmanesh R, Falconi M et al (2008) Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut and unknown primary. Neuroendocrinology 87:47-62
56. Tomassetti R Campana D, Piscitelli L et al (2005) Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 16:1806-1810
57. Vilsteren FG Van, Baskin-Bey ES, Nagorney DM et al (2006) Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transpl 12:448-456
58. Wicherts DA, De Haas RJ, Adam R (2007) Bringing unresectable liver disease to resection with curative intent. Eur J Surg Oncol 33 [Suppl 2]:42-51
59. Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid"' epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063-3072
60. Yao KA, Talamonti MS, Nemcek A et al (2001) Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130:677-682